For patients with surgery-chemotherapy (SC), significant weight loss seen within first 3 months after surgery. »
09/08/21

Elevated expression of NMU and NMUR2 in CRC tissue. »
09/07/21

Clinical dose of cisplatin (200 µM) treated SPDCs able to stimulate proliferation of cytotoxic T lymphocytes. »
09/07/21

presence of 4 or more positive LNs remained significant prognostic factor for local–regional lymph node control. »
09/18/21

Risk of heart failure and thrombophlebitis/thrombosis higher after chemotherapy. »
09/18/21

CD45Ro+ T-cells in stroma of IF and TCe independent prognostic factor for OS. »
05/31/21

Shorter time to conversion from active surveillance to treatment associated with higher-risk clinicopathological tumor features. »
09/10/21

Overall and cancer-specific survival rates significantly worse in frailty group. »
04/21/21

Novel NK cell-related prognostic biomarkers identified. »
09/10/21

Sensitivity of 77.7%, specificity of 97.8% achieved. »
05/02/21